Belgian biotech company Galapagos NV plans to spin off part of its operations, creating a new listed firm with approximately ...

NBCUniversal’s SpinCo has given its first indication of its programming strategy with the hire of Val Boreland as President ...

A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...

The executive ranks of the cable network entity spinning off from Comcast/NBCUniversal later this year have been filled in ...

Mark Lazarus, the prospective Chief Executive Officer of “SpinCo,” Comcast’s planned spin-off of select cable television networks, today announced add ...

An international research team led by the University of California, Irvine has discovered a new type of skeletal tissue that offers great potential for advancing regenerative medicine and tissue ...

Portage Biotech Inc. WESTPORT, Conn., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Portage Biotech, Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a ...

Shareholders of the private biotech could also receive a potential payment tied to an undisclosed development milestone. Madison, Wisconsin-based Nimble’s lead asset is a preclinical IL23R ...

VIR's is expected to report data in January from two phase 1 trials of VIR-5500 and VIR-5818, two T-cell engagers, in various cancer types. JANX recently produced promising data with JANX007 ...

They each operate in treatment areas with high demand. Pharmaceutical and biotech stocks often are seen as steady and safe options for investors for one particular reason. Patients need their ...

BAN2803 is at the forefront of BioArctic’s use of the tech, according to the biotech’s publicly disclosed pipeline. BMS’ decision to join the race to develop the next generation of anti ...

Now, Novartis has signed a pact with the California biotech aimed at discovering an undisclosed number of new therapeutic targets, according to a Dec. 18 release. The Swiss pharma will pay BioAge ...